Join Now
Shilpa Biocare, a division of Shilpa Medicare Group, is proud to announce that we have successfully completed FSSAI registration and obtained Kosher Certification. These milestones underscore our commitment to quality, compliance, and innovation in delivering affordable healthcare solutions through our comprehensive Contract Development and Manufacturing Organization (CDMO) services.
About Shilpa Biocare
At Shilpa Biocare, we provide end-to-end CDMO services, from clone development to commercial production, all under one roof. Our state-of-the-art facilities and expertise enable us to deliver high-quality biopharmaceutical products to meet global healthcare needs.
Key Features of Shilpa Biocare
- End-to-End CDMO Services: From clone development to commercial manufacturing
- Fermentation Capacity: Up to 230,000 liters for microbial fermentation
- Dual-System Expertise: Prokaryotic (E. coli, Bacillus) and Eukaryotic (Aspergillus, Pichia, Saccharomyces) systems
- Strain Development: In-house R&D for high-titer optimization
- Scalable Process Development: Bioreactor scale-up from 1,000L to 55,000L
- Integrated Manufacturing: Upstream, downstream, spray drying, and lyophilization
- Diverse Product Portfolio: Albumin, Insulin, Hyaluronic Acid, Peptides, and more
- Wide Application Range: API, Enzymes, Plasmid DNA, Viral Vectors, Therapeutic Proteins
- GMP-Compliant Manufacturing: Quality-driven, large-scale production
Our Commitment to Quality
With FSSAI registration and Kosher Certification, Shilpa Biocare ensures compliance with stringent regulatory standards, delivering safe and reliable products for global markets. Our GMP-compliant manufacturing processes are designed to meet the highest quality benchmarks.
Connect with Us
For more information about our CDMO services or to explore partnership opportunities, contact us:
- Email: info@vbshilpa.com
- Website: www.vbshilpa.com
Innovating for a Healthier Tomorrow
Join us in our mission to make healthcare more accessible and affordable. Shilpa Biocare is dedicated to driving innovation and excellence in biopharmaceutical manufacturing.